- Home
- SBFM vs ESNT Comparison
SBFM vs ESNT Comparison
Compare SBFM & ESNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SBFM | ESNT |
|---|---|---|
| Founded | 2006 | 2008 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0M | 5.9B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | SBFM | ESNT |
|---|---|---|
| Price | $1.05 | $58.68 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | $7.00 | ★ $67.86 |
| AVG Volume (30 Days) | 32.6K | ★ 629.8K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 2.42% |
| EPS Growth | N/A | ★ 0.73 |
| EPS | N/A | ★ 6.90 |
| Revenue | N/A | ★ $1,260,935,000.00 |
| Revenue This Year | $10.26 | N/A |
| Revenue Next Year | $32.63 | $3.18 |
| P/E Ratio | ★ N/A | $8.39 |
| Revenue Growth | N/A | ★ 1.45 |
| 52 Week Low | $1.00 | $51.61 |
| 52 Week High | $3.90 | $67.09 |
Technical Indicators
Market Signals| Indicator | SBFM | ESNT |
|---|---|---|
| Relative Strength Index (RSI) | 35.29 | 46.68 |
| Support Level | N/A | $56.84 |
| Resistance Level | $1.52 | $61.99 |
| Average True Range (ATR) | 0.05 | 1.00 |
| MACD | -0.01 | 0.14 |
| Stochastic Oscillator | 13.70 | 69.35 |
Price Performance
Historical ComparisonAbout SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About ESNT Essent Group Ltd.
Essent Group Ltd serves the housing finance industry by providing private mortgage insurance, reinsurance, risk management products, title insurance, and settlement services to mortgage lenders, borrowers, and investors to support homeownership. It provides credit protection to lenders and mortgage investors by covering a portion of the unpaid principal balance of a mortgage and certain related expenses in the event of a default. By providing capital to mitigate mortgage credit risk, the company allows lenders to make additional mortgage financing available to prospective homeowners.